Corpus Intelligence IC Memo — MORROW COUNTY HOSPITAL 2026-04-26 17:42 UTC
IC Memo — MORROW COUNTY HOSPITAL
Investment Committee Memorandum | OH | 23 beds | Grade C | EBITDA uplift $1.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MORROW COUNTY HOSPITAL

CCN 361313 | MORROW, OH | 23 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MORROW COUNTY HOSPITAL is a 23-bed suburban community hospital in MORROW, OH with $23.8M in net patient revenue and a 20.4% operating margin. The hospital serves a payer mix of 43.7% Medicare, 1.2% Medicaid, and 55.1% commercial.

Thesis: Turnaround. Our ML models identify $1.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 20.4% to 27.7% (+736bps).

Net Revenue HCRIS$23.8M
Current EBITDA COMPUTED$4.8M
Operating Margin COMPUTED20.4%
Occupancy HCRIS9.1%
Revenue / Bed COMPUTED$1.0M
Net-to-Gross HCRIS47.4%
Distress Probability ML59.4%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
76
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 20.4% places it above the state median. Among 76 size-comparable peers (12-46 beds), the median margin is -2.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-46), prioritizing same-state peers. 76 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MORROW COUNTY HOSPITAL (Target)OH23$23.8M20.4%
THE SURGICAL HOSPITAL AT SOUTHOH24$166.6M-3.1%
GALION COMMUNITY HOSPITALOH25$128.2M16.6%
MARY RUTAN HOSPITALOH39$113.0M-12.5%
MERCY HEALTH-TIFFIN HOSPITAL OH35$103.0M18.1%
JOINT TOWNSHIP DISTRICT MEMORIOH33$95.6M9.3%
FULTON COUNTY HEALTH CENTEROH25$95.2M-7.4%
UH SAMARITAN MEDICAL CENTEROH39$88.9M-3.5%
MERCER COUNTY COMMUNITY HOSPITOH42$87.8M-0.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$499K+210bp18mo
Cost to Collect4.5%2.5%$475K+200bp12mo
Denial Rate Reduction12.0%6.5%$470K+198bp12mo
A/R Days Reduction5200.0%3800.0%$289K+122bp9mo
Clean Claim Rate88.0%96.0%$15K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$499K
Cost to Collect
$475K
Denial Rate Reduction
$470K
A/R Days Reduction
$289K
Clean Claim Rate
$15K
Total EBITDA Uplift$1.7M
Current EBITDA$4.8M
+ RCM Uplift+$1.7M
Pro Forma EBITDA$6.6M
Current Margin20.4%
Pro Forma Margin27.7%
WC Released (1x)$911K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$7.5M$49.4M6.63x46.0%
Base (11x exit)10.0x11.0x$7.5M$56.8M7.62x50.1%
Bull Case9.0x11.0x$6.7M$65.0M9.69x57.5%
Bull (12x exit)9.0x12.0x$6.7M$72.9M10.87x61.2%
Bear Case11.0x10.0x$8.2M$38.3M4.67x36.1%
Bear (11x exit)11.0x11.0x$8.2M$44.8M5.46x40.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumLow occupancyAt 9.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 59.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 76 hospitals with 12-46 beds
  • Same-state prioritization (n=77)
  • Comp margins: P25=-11.8% / P50=-2.5% / P75=10.9%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.